114 related articles for article (PubMed ID: 16512975)
21. Novel therapies in lung cancer.
Hahn O; Salgia R
Hematol Oncol Clin North Am; 2005 Apr; 19(2):343-67, vii. PubMed ID: 15833410
[TBL] [Abstract][Full Text] [Related]
22. Resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
Wozniak AJ
J Thorac Oncol; 2009 Nov; 4(11 Suppl 3):S1084-5. PubMed ID: 19861927
[No Abstract] [Full Text] [Related]
23. Paradoxical clinical effects of epidermal growth factor receptor-tyrosine kinase inhibitors for acute myelogenous leukemia.
Hotta K; Kiura K; Takigawa N; Matsuo K; Tabata M; Fujiwara Y; Tanimoto M
J Clin Oncol; 2008 Dec; 26(35):5826-7; author reply 5827. PubMed ID: 19001344
[No Abstract] [Full Text] [Related]
24. Treatment of metastatic non-small-cell lung cancer.
Johnson DH; Sandler A
Chest Surg Clin N Am; 2001 Feb; 11(1):133-64. PubMed ID: 11253595
[TBL] [Abstract][Full Text] [Related]
25. Targeted therapy and new anticancer drugs in advanced disease.
Silva S; Danson S
Thorac Surg Clin; 2013 Aug; 23(3):411-9. PubMed ID: 23931023
[TBL] [Abstract][Full Text] [Related]
26. [Targeted therapy in non-small cell lung tumors: recent findings and future perspectives].
Conte PF; Barbieri F
Pathologica; 2005 Aug; 97(4):172-3. PubMed ID: 16440637
[No Abstract] [Full Text] [Related]
27. Targeted therapy in lung cancer: the good, the bad, and the ugly.
Gadgeel SM
Clin Lung Cancer; 2009 Jan; 10(1):10-2. PubMed ID: 19289366
[No Abstract] [Full Text] [Related]
28. Targeted therapy of non-small-cell lung carcinoma.
Tiwari D; Brodie SA; Brandes JC
Ther Adv Respir Dis; 2012 Feb; 6(1):41-56. PubMed ID: 21730004
[TBL] [Abstract][Full Text] [Related]
29. Molecular selection of patients for first-line treatment of advanced non-small-cell lung cancer with epidermal growth factor inhibitors: not quite ready for prime time.
Shepherd FA
J Clin Oncol; 2008 May; 26(15):2426-7. PubMed ID: 18458043
[No Abstract] [Full Text] [Related]
30. Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?
Carbognin L; Pilotto S; Peretti U; Tortora G; Bria E
Expert Opin Investig Drugs; 2016 Jun; 25(6):635-8. PubMed ID: 27054716
[No Abstract] [Full Text] [Related]
31. Agents in the preclinical development stage for non-small cell lung cancer.
Sacco PC; Sgambato A; Casaluce F; Maione P; Rossi A; Palazzolo G; Napolitano A; Gridelli C
Expert Rev Anticancer Ther; 2015; 15(11):1361-6. PubMed ID: 26485341
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of lung cancer: critical review of new agents].
Spataro V
Rev Med Suisse; 2005 Feb; 1(8):575-81. PubMed ID: 15794308
[No Abstract] [Full Text] [Related]
33. Molecule of the month. Vadimezan.
Drug News Perspect; 2009 Nov; 22(9):555. PubMed ID: 20072732
[No Abstract] [Full Text] [Related]
34. Brain metastases from non-small-cell lung cancer: is there room for improvement?
Franceschi E; Brandes AA
Expert Rev Anticancer Ther; 2012 Apr; 12(4):421-3. PubMed ID: 22500678
[No Abstract] [Full Text] [Related]
35. Treatment of patients with advanced non-small-cell lung cancer with performance status of 2: an unsolved issue.
Gridelli C
Clin Lung Cancer; 2008 Nov; 9(6):324-5. PubMed ID: 19073513
[No Abstract] [Full Text] [Related]
36. Molecular determinants of radiation response in non-small cell lung cancer.
Yom SS; Diehn M; Raben D
Semin Radiat Oncol; 2015 Apr; 25(2):67-77. PubMed ID: 25771410
[TBL] [Abstract][Full Text] [Related]
37. Marked Differences in CNS Activity among EGFR Inhibitors: Case Report and Mini-Review.
Pareek V; Welch M; Ravera E; Zampolin RL; Sequist LV; Halmos B
J Thorac Oncol; 2016 Nov; 11(11):e135-e139. PubMed ID: 27464969
[No Abstract] [Full Text] [Related]
38. Non-small-cell lung cancer: promising advances in treatment.
Quintyne KI; Walsh L; Coate L
Lancet Respir Med; 2013 Mar; 1(1):e13-4. PubMed ID: 24321810
[No Abstract] [Full Text] [Related]
39. KRAS in Non-Small-Cell Lung Cancer: Oncogenic Addiction and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Renaud S; Beau-Faller M; Massard G
JAMA Oncol; 2016 Oct; 2(10):1373. PubMed ID: 27442629
[No Abstract] [Full Text] [Related]
40. [Non-small cell lung cancer: Remarkable developments].
Vignot S; Wislez M
Bull Cancer; 2015 Dec; 102(12):962-3. PubMed ID: 26597477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
